NCT07403630 INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) Status RECRUITING Phase NA
NCT07387263 Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing Status RECRUITING Phase NA
NCT07383922 A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT07377526 Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07368218 Comparison of Transmesocolic Versus Retromesenteric Reconstruction in Cephalic Duodenopancreatectomy (FAST Trial) Status NOT_YET_RECRUITING Phase NA
NCT07360119 Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors Status NOT_YET_RECRUITING Phase NA
NCT07353645 KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT07349537 Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors Status RECRUITING Phase PHASE1
NCT07344220 Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate Status ENROLLING_BY_INVITATION Phase PHASE2
NCT07325214 Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer Status NOT_YET_RECRUITING Phase NA
NCT07318051 Sample Collection for Ongoing Research and Product Evaluation Study Status RECRUITING Phase N/A
NCT07312422 LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study Status RECRUITING Phase PHASE1/PHASE2
NCT07301814 Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors Status RECRUITING Phase N/A
NCT07300150 A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07272109 Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes Status NOT_YET_RECRUITING Phase PHASE3
NCT07254091 Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer Status RECRUITING Phase EARLY_PHASE1
NCT07252232 Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) Status RECRUITING Phase PHASE3